To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TFGTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
604 supporting clones for gene TFG back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CB111411 Liver .a 1 to 529 1 to 529   tiling clone,   529/529
(100 %)
1 diff
(99.9 %id)
DA422856 cervix .a 99 to 658 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA683299   .a 103 to 631 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
BU948298 insulinoma, Pancreas .a 140 to 723 1 to 584   tiling clone,   584/584
(100 %)
4 diff
(99.4 %id)
BU948028 insulinoma, Pancreas .a 1246 to 1887 658 to 17   tiling clone, AAA   642/642
(100 %)
1 diff
(99.9 %id)
CX761329 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1 to 717 1 to 714   tiling clone, Submitted on the opposite strand 714/840
(85 %)
4 diff
(99.6 %id)
BC001483 Brain, neuroblastoma .b 55 to 1779 1 to 1725 exact tiling clone, available from MGC, AAA   1725/1725
(100 %)
0 diff
(100 %id)
BE313040 brain, neuroblastoma .b 74 to 789 1 to 719       719/801
(89 %)
25 diff
(96.9 %id)
NM_006070.4   .c 1 to 2087 1 to 2087 exact RefSeq, AAA   2087/2087
(100 %)
0 diff
(100 %id)
AW005695 anaplastic oligodendroglioma, brain .c 38 to 348 311 to 1   tiling clone,   311/311
(100 %)
1 diff
(99.7 %id)
TI_45214116   .c 96 to 958 104 to 978       875/979
(89 %)
38 diff
(96.2 %id)
TI_45216269   .c 96 to 789 96 to 809       714/1173
(60 %)
25 diff
(97.9 %id)
AK093456 testis .c 110 to 2084 1 to 1975 exact available from FLJ,   1975/1975
(100 %)
5 diff
(99.8 %id)
DB038551 testis .c 111 to 367 2 to 259   capped   258/258
(100 %)
3 diff
(98.9 %id)
DB453387 testis .c 119 to 617 1 to 499     Submitted on the opposite strand 499/499
(100 %)
1 diff
(99.8 %id)
DA251747 caudate nucleus .c 122 to 699 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
TI_44185419   .c 136 to 867 26 to 757       732/758
(96 %)
11 diff
(98.6 %id)
BC009241 Placenta, choriocarcinoma .c 137 to 2084 1 to 1948 exact tiling clone, available from MGC, AAA   1948/1948
(100 %)
0 diff
(100 %id)
BI522632 brain .c 140 to 867 1 to 728       728/729
(99 %)
5 diff
(99.4 %id)
AW732830 choriocarcinoma, placenta .c 148 to 749 1 to 602       602/602
(100 %)
3 diff
(99.6 %id)
DA536092 heart .c 152 to 717 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BM556061 amelanotic melanoma, cell line, skin .c 153 to 1030 48 to 924       877/1134
(77 %)
15 diff
(98.7 %id)
BM554943 amelanotic melanoma, cell line, skin .c 153 to 1030 40 to 927       888/1109
(80 %)
29 diff
(97.4 %id)
CB132157 Liver .c 156 to 333 1 to 178       178/178
(100 %)
0 diff
(100 %id)
DA058348 cerebellum .c 159 to 706 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB257776 uterus .c 160 to 734 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BG699383 brain, hippocampus .c 162 to 1030 1 to 865       865/887
(97 %)
38 diff
(95.8 %id)
BI551015 brain, hippocampus .c 162 to 954 1 to 809       809/969
(83 %)
32 diff
(96.7 %id)
DA690382   .c 164 to 726 8 to 570   capped   563/563
(100 %)
0 diff
(100 %id)
DA828798 placenta .c 164 to 868 10 to 723   capped   714/720
(99 %)
14 diff
(98.1 %id)
CA429697 Cell Line, Chondrosarcoma .c 164 to 875 16 to 729     Submitted on the opposite strand 714/714
(100 %)
3 diff
(99.6 %id)
DA541238 lung .c 165 to 753 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BQ887342 carcinoma, cell line, Prostate .c 174 to 1030 1 to 856       856/885
(96 %)
18 diff
(98.0 %id)
DA071239 cerebellum .c 180 to 733 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA560173 heart .c 180 to 495 2 to 317   capped   316/316
(100 %)
0 diff
(100 %id)
BQ962954 epithelioid carcinoma cell line, Pancreas .c 180 to 1030 1 to 855       855/887
(96 %)
13 diff
(98.6 %id)
BQ920904 carcinoma, cell line, Prostate .c 180 to 1030 1 to 851       851/996
(85 %)
16 diff
(98.4 %id)
DA692289   .c 180 to 759 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA829891 placenta .c 182 to 821 2 to 644   capped   643/643
(100 %)
6 diff
(99.1 %id)
DA073988 cerebellum .c 186 to 763 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB458258 testis .c 190 to 664 1 to 475     Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
BP334964 salivary gland .c 190 to 769 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA748307   .c 191 to 752 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA039035 bladder .c 197 to 751 2 to 556   capped   555/555
(100 %)
5 diff
(99.1 %id)
DA985705 synovial membrane tissue from rheumatioidarthritis .c 198 to 763 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB501529 hypothalamus .c 199 to 680 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
BG328808 adenocarcinoma cell line, colon .c 201 to 965 1 to 761       761/949
(80 %)
21 diff
(97.8 %id)
DA579168   .c 202 to 762 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB056552 testis .c 202 to 693 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
TI_44167460   .c 203 to 1018 72 to 896       827/1103
(74 %)
39 diff
(96.5 %id)
DA061476 cerebellum .c 204 to 685 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DA205302 brain .c 204 to 775 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA552904   .c 204 to 748 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA568296 whole embryo, mainly head .c 204 to 933 2 to 738   capped   737/826
(89 %)
16 diff
(98.1 %id)
DA647088 mammary gland .c 204 to 995 2 to 796   capped   795/795
(100 %)
7 diff
(99.2 %id)
DA703933   .c 204 to 574 2 to 372   capped   371/371
(100 %)
0 diff
(100 %id)
DA574298   .c 210 to 761 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA560185 heart .c 211 to 780 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA666960   .c 211 to 732 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA692897   .c 211 to 624 2 to 415   capped   414/414
(100 %)
0 diff
(100 %id)
BI818595 pooled brain, lung, testis .c 212 to 383 1 to 172       172/172
(100 %)
0 diff
(100 %id)
BE740277 adenocarcinoma cell line, ovary .c 213 to 861 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BE740998 adenocarcinoma cell line, ovary .c 214 to 1030 1 to 814       814/1038
(78 %)
25 diff
(97.6 %id)
DB497722 hypothalamus .c 227 to 733 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
DB504116 hypothalamus .c 227 to 707 1 to 481     Submitted on the opposite strand 481/481
(100 %)
2 diff
(99.6 %id)
BJ990406 hepatoblastoma .c 227 to 809 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BU196614 ductal carcinoma, cell line, Pancreas .c 237 to 1030 1 to 792       792/996
(79 %)
9 diff
(99.1 %id)
BQ686300 ductal carcinoma, cell line, Pancreas .c 237 to 1023 1 to 790       790/867
(91 %)
7 diff
(99.2 %id)
DB452698 testis .c 238 to 713 1 to 476     Submitted on the opposite strand 476/476
(100 %)
2 diff
(99.6 %id)
DA057967 cerebellum .c 239 to 693 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DA695575   .c 239 to 823 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA729313   .c 239 to 1061 2 to 824   capped   823/823
(100 %)
8 diff
(99.1 %id)
DB475349 hippocampus .c 240 to 716 1 to 477       477/477
(100 %)
3 diff
(99.4 %id)
DB477581 hippocampus .c 240 to 737 1 to 498     Submitted on the opposite strand 498/500
(99 %)
4 diff
(99.2 %id)
TI_44349835   .c 241 to 884 114 to 758       645/758
(85 %)
12 diff
(98.5 %id)
BI755943 brain .c 246 to 1111 1 to 872       872/889
(98 %)
31 diff
(96.6 %id)
TI_57221068   .c 246 to 1111 35 to 906       872/923
(94 %)
34 diff
(96.4 %id)
AI638389 pooled germ cell tumors .c 252 to 331 80 to 1       80/80
(100 %)
0 diff
(100 %id)
AI969329 pooled germ cell tumors .c 252 to 373 122 to 1       122/122
(100 %)
0 diff
(100 %id)
BE671870 pooled germ cell tumors .c 252 to 391 140 to 1       140/140
(100 %)
0 diff
(100 %id)
BI598109 brain, hypothalamus .c 254 to 980 1 to 730       730/877
(83 %)
15 diff
(98.3 %id)
TI_45216693   .c 255 to 980 118 to 846       729/993
(73 %)
16 diff
(98.4 %id)
DA827576 pericardium .c 256 to 763 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DB459454 testis .c 259 to 732 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
DB494024 hypothalamus .c 259 to 766 1 to 508     Submitted on the opposite strand 508/508
(100 %)
2 diff
(99.7 %id)
DA697145   .c 264 to 842 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA010555 adrenal gland .c 272 to 828 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BP381023   .c 273 to 984 1 to 715       715/813
(87 %)
21 diff
(97.5 %id)
BI667937 brain, hypothalamus .c 275 to 1057 1 to 785       785/785
(100 %)
13 diff
(98.4 %id)
TI_44343895   .c 276 to 1057 88 to 871       784/871
(90 %)
15 diff
(98.3 %id)
BE242918 leukopheresis .c 286 to 611 1 to 326       326/326
(100 %)
4 diff
(98.8 %id)
BP363029 lung .c 288 to 870 1 to 583       583/583
(100 %)
0 diff
(100 %id)
TI_59381427   .c 290 to 1030 95 to 854       579/925
(62 %)
41 diff
(95.6 %id)
DB243632 stomach, tumor tissue .c 290 to 847 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BG333744 melanotic melanoma, skin .c 292 to 1030 1 to 739       739/954
(77 %)
24 diff
(97.5 %id)
DA717660   .c 293 to 842 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA229274 brain .c 295 to 843 2 to 550   capped   549/554
(99 %)
2 diff
(99.7 %id)
DA585713 lung .c 295 to 589 2 to 296   capped   295/295
(100 %)
0 diff
(100 %id)
DA625203 Kidney .c 295 to 843 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
DB245986 uterus, tumor tissue .c 295 to 788 2 to 495   capped   494/494
(100 %)
3 diff
(99.4 %id)
DB474882 hippocampus .c 298 to 794 1 to 497     Submitted on the opposite strand 497/497
(100 %)
2 diff
(99.6 %id)
BP325428 Pancreas .c 298 to 867 1 to 570       570/581
(98 %)
8 diff
(98.7 %id)
BM833809 stomach .c 298 to 822 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
BU557751 adenocarcinoma, cell line, breast .c 308 to 1179 1 to 880       880/966
(91 %)
30 diff
(96.9 %id)
BU558068 adenocarcinoma, cell line, breast .c 308 to 567 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BQ882625 eye, normal pigmented retinal epithelium .c 310 to 1108 1 to 814       812/960
(84 %)
22 diff
(97.8 %id)
CB152539 Liver .c 310 to 858 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BF027047 melanotic melanoma, skin .c 316 to 1104 1 to 777       779/791
(98 %)
27 diff
(96.6 %id)
AW250604 lung, small cell carcinoma .c 321 to 701 1 to 382       382/388
(98 %)
6 diff
(98.5 %id)
BE301872 Kidney, renal cell adenocarcinoma .c 323 to 953 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BG703776 brain, hippocampus .c 334 to 1055 1 to 722       722/722
(100 %)
8 diff
(98.9 %id)
DA600269   .c 335 to 889 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA609285   .c 335 to 867 2 to 535   capped   534/537
(99 %)
4 diff
(99.3 %id)
DA682874   .c 335 to 1140 2 to 803   capped   802/803
(99 %)
5 diff
(99.4 %id)
DA685215   .c 335 to 867 2 to 534   capped   533/538
(99 %)
2 diff
(99.7 %id)
DA689730   .c 335 to 858 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
DA734701   .c 335 to 969 2 to 635   capped   634/636
(99 %)
7 diff
(98.9 %id)
DB021407 testis .c 335 to 726 2 to 394   capped   393/396
(99 %)
1 diff
(99.8 %id)
DA086281 cerebellum .c 338 to 894 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
AL702038 human skeletal muscle .c 338 to 877 1 to 539       539/539
(100 %)
2 diff
(99.7 %id)
DB460424 testis .c 339 to 796 1 to 458     Submitted on the opposite strand 458/458
(100 %)
3 diff
(99.4 %id)
BM836557 Ascites, stomach .c 339 to 721 1 to 382       382/382
(100 %)
1 diff
(99.8 %id)
BP342115 stomach mucosa .c 339 to 904 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DA042823 bladder .c 340 to 913 2 to 575   capped   574/577
(99 %)
1 diff
(99.9 %id)
DA650567   .c 340 to 883 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA694428   .c 340 to 797 2 to 460   capped   459/459
(100 %)
2 diff
(99.6 %id)
DA837959 placenta .c 340 to 890 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB048818 testis .c 340 to 921 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DB258418 uterus .c 340 to 909 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP261860 small intestine .c 357 to 937 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA984394 synovial membrane tissue from rheumatioidarthritis .c 357 to 919 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA356468 subthalamic nucleus .c 358 to 910 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA664523   .c 358 to 1131 2 to 777   capped   776/777
(99 %)
10 diff
(98.8 %id)
DB056227 testis .c 358 to 921 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA356739 subthalamic nucleus .c 359 to 935 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA597694   .c 359 to 912 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB047709 testis .c 359 to 911 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB448926 testis .c 365 to 794 1 to 432       432/432
(100 %)
7 diff
(98.4 %id)
AW411061 muscle, rhabdomyosarcoma .c 366 to 831 1 to 466     Submitted on the opposite strand 466/466
(100 %)
6 diff
(98.8 %id)
BQ071433 brain, neuroblastoma, cell line .c 366 to 1382 1 to 1026       1026/1027
(99 %)
19 diff
(98.2 %id)
BG339376 leiomyosarcoma cell line, uterus .c 377 to 1165 1 to 771       773/786
(98 %)
32 diff
(96.0 %id)
BC023599 Uterus, leiomyosarcoma .c 378 to 2084 1 to 1707 exact available from MGC, AAA   1707/1707
(100 %)
0 diff
(100 %id)
AI871801 ovary, tumor, 5 pooled (see description) .c 383 to 887 1 to 505     Submitted on the opposite strand 505/505
(100 %)
5 diff
(99.1 %id)
AI635270 adenocarcinoma, Pancreas .c 383 to 913 1 to 531     Submitted on the opposite strand 531/532
(99 %)
2 diff
(99.7 %id)
AW075414 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 383 to 876 1 to 493     Submitted on the opposite strand 493/493
(100 %)
2 diff
(99.6 %id)
AW300784 colon, moderately differentiated adenocarcinoma .c 383 to 913 1 to 531     Submitted on the opposite strand 531/532
(99 %)
2 diff
(99.7 %id)
BE049303 adenocarcinoma, Pancreas .c 383 to 829 1 to 446     Submitted on the opposite strand 446/446
(100 %)
8 diff
(98.3 %id)
AW296965   .c 385 to 810 1 to 426     Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
AI207489 Liver .c 392 to 1058 1 to 671       671/671
(100 %)
4 diff
(99.5 %id)
BF435049 fibrotheoma, ovary .c 392 to 965 1 to 574     Submitted on the opposite strand 574/574
(100 %)
2 diff
(99.7 %id)
BM791350 stomach .c 395 to 1005 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
AI123230 pooled .c 402 to 879 1 to 478     Submitted on the opposite strand 478/486
(98 %)
1 diff
(99.8 %id)
AI075856   .c 402 to 869 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
AI422712 brain, glioblastoma (pooled) .c 402 to 1026 1 to 624     Submitted on the opposite strand 624/630
(99 %)
5 diff
(99.3 %id)
BI523468 brain .c 1426 to 2010 588 to 1       588/588
(100 %)
11 diff
(98.2 %id)
TI_44185420   .c 1426 to 2010 588 to 1       588/588
(100 %)
11 diff
(98.2 %id)
DB366839   .c 1485 to 2084 606 to 1       606/611
(99 %)
22 diff
(96.4 %id)
DB354796 whole embryo, mainly head .c 1508 to 2084 573 to 1       573/573
(100 %)
10 diff
(98.3 %id)
DB361911 mammary gland .c 1530 to 2084 554 to 1       554/554
(100 %)
2 diff
(99.7 %id)
DB337642 testis .c 1543 to 2084 543 to 1       543/543
(100 %)
3 diff
(99.5 %id)
BE208793 choriocarcinoma, placenta .c 1545 to 2085 542 to 2       541/542
(99 %)
0 diff
(100 %id)
BE208314 Kidney, renal cell adenocarcinoma .c 1551 to 2085 536 to 2   tiling clone,   535/536
(99 %)
0 diff
(100 %id)
BJ990407 hepatoblastoma .c 1567 to 2046 480 to 1       480/480
(100 %)
0 diff
(100 %id)
DB322684   .c 1570 to 2084 513 to 1       513/513
(100 %)
14 diff
(97.3 %id)
AW246723 lung, small cell carcinoma .c 1608 to 2084 487 to 11   AAA   477/477
(100 %)
3 diff
(99.4 %id)
DB322059   .c 1626 to 2084 463 to 1       463/468
(98 %)
13 diff
(97.3 %id)
DB374842 placenta .c 1640 to 2084 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
DB373405 placenta .c 1787 to 2084 299 to 2       298/299
(99 %)
0 diff
(100 %id)
DA704111   .d 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
FN166160 breast carcinoma .d 16 to 91 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
AU310047 neuroblastoma .d 20 to 599 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BI905840 leukocyte .d 26 to 815 1 to 794       794/859
(92 %)
17 diff
(98.1 %id)
TI_57231913   .d 26 to 815 36 to 829       794/894
(88 %)
22 diff
(97.6 %id)
DA056331 cerebellum .d 27 to 630 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
DA131315 alzheimer cortex .d 27 to 588 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA691589   .d 27 to 595 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA695908   .d 27 to 592 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA773283 brain .d 27 to 599 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB002022 breast, tumor tissue .d 27 to 557 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
DB029719 testis .d 27 to 614 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB103811 thymus .d 27 to 599 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA078574 cerebellum .d 29 to 584 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BE409447 choriocarcinoma, placenta .d 32 to 658 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
NM_001007565.1   .d 32 to 1828 1 to 1797 exact RefSeq, AAA   1797/1797
(100 %)
0 diff
(100 %id)
DA072678 cerebellum .d 49 to 627 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB112763 thymus .d 50 to 635 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DA259185 caudate nucleus .d 51 to 634 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA419340 cord Blood .d 51 to 608 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB463512 hippocampus .d 51 to 482 1 to 434     Submitted on the opposite strand 434/434
(100 %)
5 diff
(98.9 %id)
DB465181 hippocampus .d 51 to 482 1 to 433     Submitted on the opposite strand 433/433
(100 %)
2 diff
(99.6 %id)
DB483190 hippocampus .d 51 to 540 1 to 490     Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
DA693213   .d 51 to 601 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB120201 thymus .d 51 to 601 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA078658 cerebellum .d 52 to 605 2 to 558   capped   557/558
(99 %)
4 diff
(99.3 %id)
DB244455 uterus, tumor tissue .d 52 to 604 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB003179 breast, tumor tissue .d 53 to 596 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB060115 testis .d 53 to 262 2 to 211   capped   210/210
(100 %)
0 diff
(100 %id)
DB266475 uterus .d 53 to 626 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BM819287 stomach .d 59 to 542 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
DA066456 cerebellum .d 60 to 624 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
TI_44350407   .d 62 to 689 115 to 757       614/1240
(49 %)
34 diff
(97.3 %id)
BM832688 stomach .d 62 to 568 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BM463152 melanotic melanoma, skin .d 64 to 1182 1 to 1117       1117/1117
(100 %)
23 diff
(98.0 %id)
AU077188   .d 64 to 240 1 to 177       177/177
(100 %)
2 diff
(98.9 %id)
CX163430 human embryonic stem cells differentiated toan early endodermal cell type .d 65 to 878 1 to 814       814/814
(100 %)
0 diff
(100 %id)
BP380591   .d 65 to 608 1 to 546       546/983
(55 %)
9 diff
(99.1 %id)
BP198914 brain .d 66 to 648 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA050481   .d 67 to 637 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA264451 caudate nucleus .d 67 to 624 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
CN337638 embryonic stem cells, DMSO-treated H9 cellline .d 69 to 750 7 to 688       682/688
(99 %)
6 diff
(99.2 %id)
CF122387 CNCAP(3)T-225 cell line, Prostate .d 71 to 446 7 to 383       377/386
(97 %)
11 diff
(97.2 %id)
TI_154181959   .d 71 to 458 78 to 466       389/856
(45 %)
13 diff
(98.5 %id)
BI561875 testis .d 72 to 689 1 to 633       604/1116
(54 %)
31 diff
(97.3 %id)
BG721561 testis .d 76 to 717 1 to 642       642/642
(100 %)
5 diff
(99.3 %id)
CX166845 human embryonic stem cells differentiated toan early endodermal cell type .d 76 to 783 1 to 708       708/708
(100 %)
0 diff
(100 %id)
CX784522 human embryonic stem cells .d 76 to 760 1 to 685       685/685
(100 %)
0 diff
(100 %id)
BE243072 leukopheresis .d 76 to 412 1 to 338       338/338
(100 %)
2 diff
(99.5 %id)
BE242844 leukopheresis .d 76 to 498 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
DB445930 testis .d 77 to 548 1 to 473     Submitted on the opposite strand 473/473
(100 %)
4 diff
(99.2 %id)
DA015064 adrenal gland .d 78 to 658 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
DA285965 corpus callosum .d 78 to 571 2 to 495   capped   494/494
(100 %)
1 diff
(99.8 %id)
BX367248   .d 78 to 905 1 to 826       826/826
(100 %)
8 diff
(99.1 %id)
DA700063   .d 78 to 600 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
BP380654   .d 78 to 661 1 to 582       582/583
(99 %)
9 diff
(98.5 %id)
DA361255 subthalamic nucleus .d 81 to 621 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
CN337641 embryonic stem cells, cell lines H1, H7, andH9 .d 84 to 848 1 to 765       765/765
(100 %)
3 diff
(99.7 %id)
CN337645 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 84 to 734 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
CN337647 embryonic stem cells, cell lines H1, H7, andH9 .d 92 to 802 1 to 711       711/711
(100 %)
3 diff
(99.6 %id)
CR598132 HeLa cells Cot 25-normalized .d 94 to 1789 1 to 1696 exact tiling clone,   1696/1696
(100 %)
0 diff
(100 %id)
AL555972 placenta .d 94 to 918 1 to 829       829/829
(100 %)
7 diff
(99.2 %id)
TI_57177588   .d 94 to 926 30 to 865       833/865
(96 %)
13 diff
(98.5 %id)
CN337646 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 95 to 734 1 to 640       640/640
(100 %)
4 diff
(99.4 %id)
CX754590 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 95 to 815 1 to 721     Submitted on the opposite strand 721/721
(100 %)
0 diff
(100 %id)
CX760922 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 95 to 641 1 to 547     Submitted on the opposite strand 547/547
(100 %)
0 diff
(100 %id)
BI766361 pooled lung and spleen .d 99 to 926 1 to 831       828/831
(99 %)
8 diff
(99.1 %id)
AW402197 lymph .d 101 to 549 8 to 456       449/456
(98 %)
10 diff
(97.9 %id)
TI_154138511   .d 101 to 608 79 to 586       508/510
(99 %)
2 diff
(99.7 %id)
BI918649 brain .d 111 to 878 29 to 792       766/792
(96 %)
16 diff
(98.0 %id)
TI_57240950   .d 111 to 878 29 to 792       766/792
(96 %)
16 diff
(98.0 %id)
TI_57150008   .d 147 to 810 100 to 796       640/800
(80 %)
38 diff
(95.3 %id)
AA205519   .d 150 to 424 24 to 306       283/309
(91 %)
11 diff
(96.5 %id)
BP269948 thyroid .d 150 to 719 1 to 570       570/581
(98 %)
3 diff
(99.5 %id)
AA706675 parathyroid gland, parathyroid tumor .d 154 to 483 1 to 330     Submitted on the opposite strand 330/330
(100 %)
1 diff
(99.7 %id)
AA725201 parathyroid gland, parathyroid tumor .d 154 to 622 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
W04516 parathyroid gland, parathyroid tumor .d 154 to 605 1 to 456     Submitted on the opposite strand 456/456
(100 %)
3 diff
(99.4 %id)
AA236931 germinal center B cell .d 154 to 711 1 to 558     Submitted on the opposite strand 558/559
(99 %)
10 diff
(98.3 %id)
AA291132 germinal center B cell .d 154 to 595 1 to 442     Submitted on the opposite strand 442/442
(100 %)
2 diff
(99.6 %id)
AA291663 ovarian tumor, ovary .d 154 to 536 1 to 382     Submitted on the opposite strand 382/382
(100 %)
9 diff
(97.7 %id)
AA428782 ovarian tumor, ovary .d 154 to 646 1 to 493     Submitted on the opposite strand 493/493
(100 %)
1 diff
(99.8 %id)
AA676750 whole brain .d 154 to 608 1 to 455     Submitted on the opposite strand 455/457
(99 %)
7 diff
(98.5 %id)
AA843908 parathyroid gland, parathyroid tumor .d 154 to 698 1 to 545     Submitted on the opposite strand 545/545
(100 %)
2 diff
(99.7 %id)
AA922048 pooled .d 154 to 873 1 to 721     Submitted on the opposite strand 721/721
(100 %)
11 diff
(98.5 %id)
AA976656 carcinoid, lung .d 154 to 585 1 to 432     Submitted on the opposite strand 432/433
(99 %)
2 diff
(99.6 %id)
AI160566 placenta .d 154 to 652 1 to 499     Submitted on the opposite strand 499/499
(100 %)
2 diff
(99.6 %id)
AI193493 lung .d 154 to 528 1 to 375     Submitted on the opposite strand 375/375
(100 %)
2 diff
(99.5 %id)
AI244672 Kidney .d 154 to 601 1 to 448     Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
AI281020 adenocarcinoma, colon .d 154 to 654 1 to 501     Submitted on the opposite strand 501/502
(99 %)
3 diff
(99.5 %id)
AI283875 adenocarcinoma, colon .d 154 to 706 1 to 553     Submitted on the opposite strand 553/553
(100 %)
2 diff
(99.7 %id)
AI310955 2 pooled tumors (clear cell type), Kidney .d 154 to 607 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
AI359340 brain, glioblastoma (pooled) .d 154 to 610 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AI400037 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 154 to 628 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
AI680789 carcinoid, lung .d 154 to 620 1 to 467     Submitted on the opposite strand 467/475
(98 %)
2 diff
(99.6 %id)
AI632912 carcinoid, lung .d 154 to 793 1 to 640     Submitted on the opposite strand 640/640
(100 %)
1 diff
(99.9 %id)
AI671585 pooled germ cell tumors .d 154 to 593 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI694958 carcinoid, lung .d 154 to 628 1 to 475     Submitted on the opposite strand 475/475
(100 %)
2 diff
(99.6 %id)
AI660198 thymus, pooled .d 154 to 654 1 to 501     Submitted on the opposite strand 501/502
(99 %)
4 diff
(99.3 %id)
AI814382 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 154 to 703 1 to 550     Submitted on the opposite strand 550/550
(100 %)
2 diff
(99.7 %id)
AI818639 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 154 to 608 1 to 455     Submitted on the opposite strand 455/475
(95 %)
2 diff
(99.6 %id)
AI860290 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 154 to 771 1 to 617     Submitted on the opposite strand 617/619
(99 %)
8 diff
(98.8 %id)
AI924781 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 154 to 786 1 to 633     Submitted on the opposite strand 633/634
(99 %)
1 diff
(99.9 %id)
AW058473 Kidney .d 154 to 664 1 to 511     Submitted on the opposite strand 511/511
(100 %)
0 diff
(100 %id)
AW131753 brain, medulloblastoma .d 154 to 704 1 to 550     Submitted on the opposite strand 550/550
(100 %)
1 diff
(99.9 %id)
BE045620 carcinoid, lung .d 154 to 666 1 to 509     Submitted on the opposite strand 509/509
(100 %)
2 diff
(99.7 %id)
AW629353 pooled .d 154 to 608 1 to 455     Submitted on the opposite strand 455/458
(99 %)
7 diff
(98.5 %id)
BE467781 carcinoid, lung .d 154 to 830 1 to 676     Submitted on the opposite strand 676/676
(100 %)
9 diff
(98.7 %id)
BE646134 Prostate .d 154 to 608 1 to 455     Submitted on the opposite strand 455/460
(98 %)
2 diff
(99.6 %id)
BF058266 fibrotheoma, ovary .d 154 to 574 1 to 421     Submitted on the opposite strand 421/421
(100 %)
3 diff
(99.3 %id)
BF057492 fibrotheoma, ovary .d 154 to 837 1 to 685     Submitted on the opposite strand 685/709
(96 %)
16 diff
(97.8 %id)
BF434126 fibrotheoma, ovary .d 154 to 685 1 to 532     Submitted on the opposite strand 532/532
(100 %)
1 diff
(99.9 %id)
AI935809 Kidney .d 156 to 654 1 to 499     Submitted on the opposite strand 499/500
(99 %)
6 diff
(98.8 %id)
AI910689 Kidney .d 158 to 650 1 to 490     Submitted on the opposite strand 492/491
(100 %)
8 diff
(98.4 %id)
AA094787   .d 160 to 319 1 to 160       160/160
(100 %)
1 diff
(99.4 %id)
N46273 melanocyte .d 160 to 510 1 to 354       354/358
(98 %)
9 diff
(97.5 %id)
BM547476 ovary (pool of 3) .d 160 to 1010 1 to 854       852/1113
(76 %)
15 diff
(98.7 %id)
BF433359 carcinoid, lung .d 164 to 709 1 to 546     Submitted on the opposite strand 546/546
(100 %)
0 diff
(100 %id)
BQ631388 Pancreas, Purified pancreatic islet .d 165 to 598 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
CA848301 Pancreas, Purified pancreatic islet .d 165 to 661 1 to 497     Submitted on the opposite strand 497/497
(100 %)
0 diff
(100 %id)
CB131320 Liver .d 166 to 652 1 to 487       487/487
(100 %)
0 diff
(100 %id)
AA888898 parathyroid gland, parathyroid tumor .d 168 to 521 1 to 353     Submitted on the opposite strand 353/353
(100 %)
1 diff
(99.8 %id)
BE045734 carcinoid, lung .d 169 to 802 1 to 634     Submitted on the opposite strand 634/634
(100 %)
2 diff
(99.7 %id)
BM834284 stomach .d 169 to 760 1 to 592       592/592
(100 %)
0 diff
(100 %id)
DA380327 thalamus .d 170 to 707 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BG260179 bladder, transitional cell papilloma, cell line .d 171 to 906 1 to 734       734/802
(91 %)
3 diff
(99.7 %id)
Y07968 Pancreas .d 173 to 1825 1 to 1658 I13V AAA   1658/1658
(100 %)
5 diff
(99.7 %id)
AA384848 thyroid gland .d 179 to 512 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
CF595762 Stomach, adenocarcinoma .d 179 to 820 1 to 646       646/750
(86 %)
15 diff
(98.0 %id)
BE079712 breast .d 183 to 661 479 to 1     Submitted on the opposite strand 479/479
(100 %)
5 diff
(99.0 %id)
AA724962 parathyroid gland, parathyroid tumor .d 187 to 871 1 to 685     Submitted on the opposite strand 685/685
(100 %)
18 diff
(97.4 %id)
BT007428   .d 191 to 1392 1 to 1202       1202/1203
(99 %)
1 diff
(100.0 %id)
CR456781   .d 191 to 1393 1 to 1203 exact     1203/1203
(100 %)
1 diff
(100.0 %id)
BF926906 nervous_tumor .d 198 to 563 1 to 366       366/366
(100 %)
0 diff
(100 %id)
CD621759   .d 201 to 870 686 to 15       672/686
(97 %)
7 diff
(99.0 %id)
CX871794 embryonic stem .d 226 to 620 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
AA226986 brain, neuroepithelial cells .d 229 to 582 7 to 360       354/360
(98 %)
0 diff
(100 %id)
H48385 liver and spleen .d 239 to 659 1 to 427       427/427
(100 %)
6 diff
(98.6 %id)
AW889481 nervous_tumor .d 244 to 469 1 to 226       226/226
(100 %)
1 diff
(99.6 %id)
CN337643 embryonic stem cells, cell lines H1, H7, andH9 .d 254 to 991 1 to 737       737/737
(100 %)
1 diff
(99.9 %id)
CB269244 adipose .d 262 to 739 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
BP256797 Kidney .d 262 to 848 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BP209414 cerebellum .d 267 to 847 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CB139574 Liver .d 271 to 657 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BM829085 Ascites, stomach .d 279 to 608 1 to 330       330/334
(98 %)
2 diff
(99.5 %id)
CN337649 embryonic stem cells, DMSO-treated H9 cellline .d 281 to 850 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
BP268751 thyroid .d 283 to 855 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BP269182 thyroid .d 283 to 854 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BP337579 coronary artery .d 285 to 869 1 to 586       586/587
(99 %)
7 diff
(98.9 %id)
BP214993 corpus callosum .d 286 to 866 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BG287513 bladder, transitional cell papilloma, cell line .d 286 to 1003 1 to 708       708/860
(82 %)
20 diff
(97.7 %id)
CB123657 Liver .d 291 to 908 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BQ216366 melanotic melanoma, skin .d 293 to 1151 1 to 860       860/860
(100 %)
4 diff
(99.6 %id)
BE883042 leiomyosarcoma, uterus .d 295 to 1011 1 to 722       722/920
(78 %)
14 diff
(98.5 %id)
BM834879 stomach .d 295 to 770 1 to 476       476/476
(100 %)
0 diff
(100 %id)
CB132078 Liver .d 297 to 760 1 to 464       464/464
(100 %)
0 diff
(100 %id)
CB150100 Liver .d 297 to 617 1 to 321       321/321
(100 %)
4 diff
(98.8 %id)
BP208097 cerebellum .d 298 to 875 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
CA773128 Pancreas, Purified pancreatic islet .d 298 to 874 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DA086354 cerebellum .d 299 to 612 2 to 315   capped   314/329
(95 %)
4 diff
(98.8 %id)
BM834304 stomach .d 299 to 872 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BP376447 uterus .d 299 to 849 1 to 551       551/551
(100 %)
0 diff
(100 %id)
DA737598   .d 300 to 1159 2 to 864   capped   863/863
(100 %)
9 diff
(99.0 %id)
BM837749 Ascites, stomach .d 301 to 1026 1 to 726       726/726
(100 %)
0 diff
(100 %id)
BP325677 Pancreas .d 302 to 883 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA831125 placenta .d 303 to 1010 2 to 712   capped   711/751
(94 %)
8 diff
(99.0 %id)
BU166787 melanotic melanoma, skin .d 310 to 1151 1 to 844       844/844
(100 %)
3 diff
(99.7 %id)
DA847972 placenta .d 316 to 827 2 to 514   capped   513/513
(100 %)
3 diff
(99.5 %id)
BM759553 Ascites, stomach .d 341 to 1025 1 to 685       685/685
(100 %)
0 diff
(100 %id)
BM825839 Ascites, stomach .d 350 to 717 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
CB115477 Liver .d 355 to 617 1 to 263       263/263
(100 %)
3 diff
(98.9 %id)
CF596101 Stomach, adenocarcinoma .d 358 to 1103 1 to 756       756/759
(99 %)
19 diff
(97.5 %id)
CF141426 CNCAP(3)T-225 cell line, Prostate .d 383 to 883 8 to 508       501/508
(98 %)
6 diff
(98.9 %id)
TI_154172176   .d 383 to 1017 90 to 726       637/1143
(55 %)
22 diff
(98.1 %id)
BQ227285 epithelioid carcinoma, Pancreas .d 402 to 1177 12 to 787       776/787
(98 %)
7 diff
(99.2 %id)
BG762353 melanotic melanoma, high MDR (cell line), skin .d 403 to 1196 1 to 797       797/800
(99 %)
5 diff
(99.4 %id)
AI272347 brain, oligodendroglioma .d 420 to 661 1 to 243     Submitted on the opposite strand 243/243
(100 %)
1 diff
(99.6 %id)
AA307334 colon .d 422 to 907 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
BM809684 amelanotic melanoma, cell line, skin .d 427 to 1468 1 to 1050       1050/1052
(99 %)
35 diff
(96.7 %id)
BE612576 adenocarcinoma, ovary .d 470 to 1010 1 to 537       537/918
(58 %)
6 diff
(99.4 %id)
CN337636 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 476 to 1277 1 to 802       802/802
(100 %)
1 diff
(99.9 %id)
CB126095 cervix, Uterine .d 491 to 912 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BP430493   .d 499 to 863 1 to 365       365/365
(100 %)
4 diff
(99.0 %id)
BP429342   .d 500 to 857 1 to 358       358/358
(100 %)
3 diff
(99.2 %id)
BU147045 brain, neuroblastoma, cell line .d 519 to 1406 1 to 892       892/892
(100 %)
4 diff
(99.6 %id)
TI_1948154104   .d 519 to 1392 997 to 127       871/1368
(63 %)
10 diff
(99.3 %id)
BQ222395 epithelioid carcinoma, Pancreas .d 521 to 1329 1 to 818       818/932
(87 %)
17 diff
(98.2 %id)
TI_1948154366   .d 604 to 1392 924 to 126       799/1458
(54 %)
21 diff
(98.6 %id)
TI_1948154192   .d 606 to 1392 912 to 126       787/1422
(55 %)
14 diff
(99.1 %id)
AA429073 ovarian tumor, ovary .d 623 to 1135 525 to 15     Submitted on the opposite strand 511/525
(97 %)
3 diff
(99.5 %id)
BQ679700 melanotic melanoma, cell line, skin .d 627 to 1536 1 to 929       929/970
(95 %)
26 diff
(97.4 %id)
BE745265 adenocarcinoma cell line, ovary .d 641 to 1421 1 to 763       763/969
(78 %)
21 diff
(97.9 %id)
CB152510 Liver .d 658 to 1230 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BE768754 prostate_tumor .d 680 to 946 1 to 267       267/267
(100 %)
0 diff
(100 %id)
BI030719 marrow .d 680 to 899 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
BQ673902 epidermoid carcinoma, cell line, salivary gland .d 680 to 1601 1 to 926       926/926
(100 %)
26 diff
(97.2 %id)
AI636311 adenocarcinoma, Pancreas .d 685 to 861 1 to 178     Submitted on the opposite strand 178/178
(100 %)
12 diff
(93.3 %id)
CD621760   .d 702 to 870 1 to 169       169/169
(100 %)
0 diff
(100 %id)
BQ669017 epidermoid carcinoma, cell line, salivary gland .d 703 to 1594 1 to 905       905/925
(97 %)
19 diff
(98.0 %id)
BI764934 pooled colon, kidney, stomach .d 715 to 1638 1 to 924       924/953
(96 %)
31 diff
(96.8 %id)
TI_57149858   .d 715 to 1638 34 to 957       924/986
(93 %)
37 diff
(96.3 %id)
ES311053 scalp interfollicular dermis, skin .d 716 to 1224 1 to 509       509/509
(100 %)
4 diff
(99.3 %id)
BI259459 cervical carcinoma cell line, cervix .d 726 to 1593 1 to 867       867/869
(99 %)
25 diff
(97.2 %id)
CD673824 eye, lens .d 738 to 1270 1 to 533   fully sequenced,   533/533
(100 %)
4 diff
(99.3 %id)
BG686143 B-cells, primary B-cells from tonsils (cell line) .d 753 to 1538 1 to 791       791/988
(80 %)
20 diff
(98.0 %id)
BI554022 anaplastic oligodendroglioma with 1p/19qloss, brain .d 753 to 1540 1 to 793       793/879
(90 %)
16 diff
(98.2 %id)
TI_44385014   .d 753 to 1485 135 to 871       737/740
(99 %)
16 diff
(97.9 %id)
TI_44385015   .d 753 to 1540 107 to 899       793/879
(90 %)
16 diff
(98.2 %id)
BQ919402 large cell carcinoma, lung .d 755 to 1697 1 to 940       940/940
(100 %)
40 diff
(95.8 %id)
BG183763   .d 766 to 1535 1 to 769       769/771
(99 %)
12 diff
(98.5 %id)
BG196715   .d 766 to 1593 1 to 821       821/911
(90 %)
30 diff
(96.8 %id)
BG197231   .d 766 to 1597 1 to 829       829/829
(100 %)
55 diff
(93.4 %id)
BG205556   .d 766 to 1628 1 to 847       847/908
(93 %)
50 diff
(94.5 %id)
BG216170   .d 766 to 1594 1 to 809       809/923
(87 %)
47 diff
(95.0 %id)
BG218681   .d 766 to 1561 1 to 795       795/796
(99 %)
10 diff
(98.8 %id)
BG218682   .d 766 to 1551 1 to 785       785/785
(100 %)
12 diff
(98.5 %id)
BG219689   .d 766 to 1552 1 to 784       784/784
(100 %)
18 diff
(97.8 %id)
TI_1948154281   .d 766 to 1392 758 to 125       634/1449
(43 %)
26 diff
(98.3 %id)
BG195207   .d 768 to 1543 1 to 775       775/775
(100 %)
11 diff
(98.6 %id)
BG184284   .d 769 to 1541 1 to 770       770/781
(98 %)
27 diff
(96.6 %id)
BG191612   .d 769 to 1544 1 to 768       768/770
(99 %)
19 diff
(97.6 %id)
BG211258   .d 769 to 1535 1 to 768       768/772
(99 %)
24 diff
(96.9 %id)
BG184283   .d 782 to 1159 1 to 378       378/378
(100 %)
0 diff
(100 %id)
BG199294   .d 782 to 1520 1 to 737       737/933
(78 %)
14 diff
(98.5 %id)
BG220656   .d 782 to 1649 1 to 859       859/922
(93 %)
48 diff
(94.8 %id)
CX762063 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 821 to 1509 689 to 1     Submitted on the opposite strand 689/847
(81 %)
5 diff
(99.5 %id)
BU633565 cell lines, Chondrosarcoma .d 834 to 1555 740 to 19   AAA   722/722
(100 %)
2 diff
(99.8 %id)
AY532911   .d 863 to 1016 1 to 154       154/174
(88 %)
3 diff
(98.3 %id)
CD242592 brain, Pituitary .d 877 to 1736 1 to 869       869/914
(95 %)
23 diff
(97.5 %id)
BG028096 Bone, osteosarcoma, cell line .d 900 to 1682 1 to 780       780/867
(89 %)
27 diff
(96.9 %id)
BG183249   .d 907 to 1722 1 to 821       821/821
(100 %)
27 diff
(96.8 %id)
BG215532   .d 907 to 1715 1 to 807       807/807
(100 %)
21 diff
(97.4 %id)
BG199293   .d 908 to 1643 37 to 771       735/782
(93 %)
9 diff
(98.9 %id)
TI_149297737   .d 912 to 1825 959 to 65   AAA   890/982
(90 %)
28 diff
(97.2 %id)
TI_227714070   .d 912 to 1825 989 to 97   AAA   888/985
(90 %)
24 diff
(97.6 %id)
BG199820   .d 914 to 1058 1 to 145       145/145
(100 %)
0 diff
(100 %id)
BG200717   .d 914 to 1143 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
BG203427   .d 914 to 1703 1 to 778       778/780
(99 %)
14 diff
(98.3 %id)
BG205553   .d 914 to 1717 1 to 799       799/801
(99 %)
39 diff
(95.2 %id)
BG210219   .d 914 to 1691 1 to 776       776/807
(96 %)
55 diff
(93.2 %id)
BG214993   .d 914 to 1663 1 to 749       749/749
(100 %)
10 diff
(98.7 %id)
AL578343 placenta .d 924 to 1789 865 to 1       865/869
(99 %)
14 diff
(98.4 %id)
BG179704 adenocarcinoma, cell line, Prostate .d 928 to 1751 1 to 820       820/913
(89 %)
24 diff
(97.4 %id)
BG192645   .d 929 to 1636 1 to 708       708/710
(99 %)
17 diff
(97.7 %id)
CN337650 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 940 to 1634 9 to 704       696/704
(98 %)
8 diff
(98.9 %id)
BG207782   .d 941 to 1275 1 to 335       335/336
(99 %)
2 diff
(99.5 %id)
TI_154188135   .d 944 to 1707 887 to 123     Submitted on the opposite strand 765/937
(81 %)
23 diff
(97.6 %id)
BM697288 eye, lens .d 968 to 1458 1 to 491   fully sequenced,   491/491
(100 %)
0 diff
(100 %id)
CB118584 Liver .d 999 to 1656 1 to 658       658/658
(100 %)
6 diff
(99.1 %id)
BG195206   .d 1006 to 1832 1 to 814       814/886
(91 %)
32 diff
(96.4 %id)
BI038144 nervous_tumor .d 1006 to 1205 13 to 215       203/215
(94 %)
6 diff
(97.3 %id)
CR603441 Placenta Cot 25-normalized .d 1006 to 1782 1 to 777       777/777
(100 %)
0 diff
(100 %id)
EC479836 Prostate .d 1006 to 1088 1 to 83       83/94
(88 %)
4 diff
(95.8 %id)
BE613143 adenocarcinoma, ovary .d 1006 to 1774 770 to 1       770/973
(79 %)
11 diff
(98.9 %id)
TI_154046397   .d 1007 to 1825 914 to 102   AAA   813/1016
(80 %)
11 diff
(99.0 %id)
TI_154060980   .d 1007 to 1825 926 to 112   AAA   815/989
(82 %)
10 diff
(99.0 %id)
TI_154131836   .d 1007 to 1825 893 to 82   AAA   812/961
(84 %)
12 diff
(98.8 %id)
TI_159696509   .d 1007 to 1825 894 to 86   AAA   809/1005
(80 %)
16 diff
(98.5 %id)
BI871016 adenocarcinoma, cell line, Liver .d 1010 to 1825 1 to 822       822/835
(98 %)
23 diff
(97.3 %id)
TI_57230992   .d 1010 to 1825 56 to 877       822/835
(98 %)
23 diff
(97.3 %id)
CR974888 T-Lymphocytes .d 1010 to 1825 1 to 816   AAA   816/816
(100 %)
0 diff
(100 %id)
TI_149314434   .d 1011 to 1828 886 to 78   AAA   809/944
(85 %)
18 diff
(98.1 %id)
BG201455   .d 1018 to 1779 13 to 769       757/771
(98 %)
17 diff
(97.8 %id)
BX367247   .d 1024 to 1791 774 to 6       769/774
(99 %)
0 diff
(100 %id)
BU532016 mixed (pool of 40 RNAs) .d 1025 to 1775 1 to 748       748/749
(99 %)
9 diff
(98.8 %id)
BM746664 Ascites, stomach .d 1027 to 1602 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BM788248 Ascites, stomach .d 1027 to 1671 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BG215533   .d 1029 to 1806 1 to 775       775/775
(100 %)
14 diff
(98.2 %id)
BU570974 brain, glioblastoma .d 1030 to 1824 1 to 804       804/814
(98 %)
27 diff
(96.7 %id)
TI_159723668   .d 1033 to 1825 869 to 77   AAA   793/1005
(78 %)
9 diff
(99.2 %id)
BU956778 adenocarcinoma, cell line, breast .d 1046 to 1825 1 to 780   AAA   780/780
(100 %)
1 diff
(99.9 %id)
CX787803 human embryonic stem cells .d 1047 to 1825 794 to 16   AAA Submitted on the opposite strand 779/779
(100 %)
0 diff
(100 %id)
CR616150 Neuroblastoma Cot 25-normalized .d 1067 to 1826 1 to 760       760/760
(100 %)
0 diff
(100 %id)
BX387435 Neuroblastoma Cot 25-normalized .d 1067 to 1826 1 to 759       759/759
(100 %)
1 diff
(99.9 %id)
BX387436 Neuroblastoma Cot 25-normalized .d 1067 to 1826 1 to 761       761/761
(100 %)
5 diff
(99.4 %id)
AW195902 pooled .d 1069 to 1826 756 to 2       755/798
(94 %)
0 diff
(100 %id)
CB242032 Human Lung Epithelial cells, lung .d 1083 to 1825 760 to 19   AAA   742/742
(100 %)
5 diff
(99.4 %id)
BG028545 Bone, osteosarcoma, cell line .d 1090 to 1824 1 to 724   AAA   724/724
(100 %)
18 diff
(97.6 %id)
BG217671   .d 1101 to 1825 742 to 18   AAA Submitted on the opposite strand 725/728
(99 %)
4 diff
(99.5 %id)
CX758499 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1106 to 1825 747 to 29   AAA   719/719
(100 %)
4 diff
(99.5 %id)
BQ325259 colon_ins .d 1107 to 1644 540 to 1       540/541
(99 %)
11 diff
(98.0 %id)
BU608553 Human Lung Epithelial cells, lung .d 1108 to 1825 736 to 19   AAA   718/718
(100 %)
5 diff
(99.4 %id)
BE894486 melanotic melanoma, skin .d 1109 to 1826 1 to 718       718/725
(99 %)
12 diff
(98.4 %id)
BG190984   .d 1110 to 1825 731 to 15   AAA Submitted on the opposite strand 717/717
(100 %)
23 diff
(96.8 %id)
CF141852 CNCAP(3)T-225 cell line, Prostate .d 1127 to 1598 8 to 479       472/479
(98 %)
6 diff
(98.8 %id)
TI_154172718   .d 1127 to 1826 88 to 793       706/1061
(66 %)
35 diff
(96.8 %id)
BQ446200 Knee, Osteoarthritic Cartilage .d 1129 to 1825 715 to 19   AAA   697/697
(100 %)
0 diff
(100 %id)
DR158437 human embryonic stem cells differentiated toan early endodermal cell type .d 1130 to 1825 717 to 21   AAA Submitted on the opposite strand 697/697
(100 %)
1 diff
(99.9 %id)
CA420436 Bone, Enchondroma cell line .d 1130 to 1825 714 to 19   AAA   696/696
(100 %)
1 diff
(99.9 %id)
BE894115 melanotic melanoma, skin .d 1134 to 1809 675 to 1     Submitted on the opposite strand 675/927
(72 %)
9 diff
(99.1 %id)
CA945190 Human Lung Epithelial cells, lung .d 1135 to 1825 708 to 19   AAA   690/690
(100 %)
1 diff
(99.9 %id)
TI_154187811   .d 1149 to 1804 769 to 123     Submitted on the opposite strand 647/886
(73 %)
11 diff
(98.8 %id)
TI_154020569   .d 1160 to 1828 759 to 92   AAA   668/673
(99 %)
3 diff
(99.6 %id)
CN337642 embryonic stem cells, DMSO-treated H9 cellline .d 1162 to 1823 662 to 1     Submitted on the opposite strand 662/662
(100 %)
0 diff
(100 %id)
CR619391 HeLa cells Cot 25-normalized .d 1167 to 1826 1 to 660       660/660
(100 %)
0 diff
(100 %id)
AA506538 Liver .d 1171 to 1603 8 to 440       433/440
(98 %)
6 diff
(98.7 %id)
FN074794 breast carcinoma .d 1176 to 1240 65 to 1     Submitted on the opposite strand 65/66
(98 %)
0 diff
(100 %id)
CX871873 embryonic stem .d 1176 to 1826 654 to 5     Submitted on the opposite strand 650/654
(99 %)
0 diff
(100 %id)
BQ631667 Pancreas, Purified pancreatic islet .d 1181 to 1825 674 to 30   AAA Submitted on the opposite strand 645/645
(100 %)
6 diff
(99.1 %id)
TI_149289181   .d 1182 to 1825 731 to 92   AAA   640/642
(99 %)
10 diff
(98.5 %id)
CF243145 Brain glioblastoma .d 1192 to 1825 650 to 19   AAA Submitted on the opposite strand 632/680
(92 %)
3 diff
(99.6 %id)
BU782651 insulinoma, Pancreas .d 1193 to 1825 648 to 16   AAA   633/633
(100 %)
0 diff
(100 %id)
CA420341 Bone, Enchondroma cell line .d 1198 to 1825 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
AA341739 Kidney .d 1239 to 1489 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
AA042844 uterus .d 1239 to 1594 1 to 356   fully sequenced,   356/356
(100 %)
0 diff
(100 %id)
CD673823 eye, lens .d 1240 to 1825 602 to 17   fully sequenced, AAA   586/586
(100 %)
1 diff
(99.9 %id)
CX787166 human embryonic stem cells .d 1241 to 1825 615 to 31   AAA Submitted on the opposite strand 585/585
(100 %)
5 diff
(99.2 %id)
DB370208   .d 1271 to 1825 559 to 1       559/560
(99 %)
10 diff
(98.3 %id)
N36956 melanocyte .d 1277 to 1825 563 to 16   AAA   548/550
(99 %)
4 diff
(99.3 %id)
BM840649 lymph node, stomach .d 1289 to 1820 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BM840651 lymph node, stomach .d 1289 to 1824 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BM841163 lymph node, stomach .d 1289 to 1824 1 to 536       536/536
(100 %)
0 diff
(100 %id)
CD676165 eye, lens .d 1295 to 1825 550 to 20   AAA Submitted on the opposite strand 531/531
(100 %)
1 diff
(99.9 %id)
DV462517 cochlea, ear .d 1298 to 1454 157 to 1     Submitted on the opposite strand 157/157
(100 %)
0 diff
(100 %id)
AA405254 ovarian tumor, ovary .d 1299 to 1822 524 to 1     Submitted on the opposite strand 524/524
(100 %)
2 diff
(99.7 %id)
AU310048 neuroblastoma .d 1306 to 1825 542 to 23   AAA   520/520
(100 %)
0 diff
(100 %id)
BU185399 ductal carcinoma, cell line, Pancreas .d 1308 to 1828 1 to 521   tiling clone, AAA   521/521
(100 %)
0 diff
(100 %id)
BQ752509 Prostate .d 1311 to 1825 527 to 13   AAA Submitted on the opposite strand 515/518
(99 %)
0 diff
(100 %id)
DB568820 hypothalamus .d 1339 to 1825 1 to 487     Submitted on the opposite strand 487/487
(100 %)
3 diff
(99.4 %id)
DB576651 hypothalamus .d 1346 to 1825 1 to 480     Submitted on the opposite strand 480/480
(100 %)
2 diff
(99.6 %id)
DB376629 placenta .d 1348 to 1825 477 to 1       477/480
(99 %)
6 diff
(98.8 %id)
DB572731 hypothalamus .d 1351 to 1825 1 to 475     Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
DB524919 testis .d 1352 to 1825 1 to 474     Submitted on the opposite strand 474/474
(100 %)
2 diff
(99.6 %id)
DB544172 hippocampus .d 1352 to 1824 1 to 473     Submitted on the opposite strand 473/474
(99 %)
3 diff
(99.4 %id)
AA147937   .d 1400 to 1811 1 to 411   fully sequenced,   411/411
(100 %)
1 diff
(99.8 %id)
CX163351 human embryonic stem cells differentiated toan early endodermal cell type .d 1410 to 1825 456 to 41   AAA   416/416
(100 %)
9 diff
(97.9 %id)
CA848591 Pancreas, Purified pancreatic islet .d 1421 to 1828 436 to 29   AAA Submitted on the opposite strand 408/408
(100 %)
0 diff
(100 %id)
FN146895 breast carcinoma .d 1424 to 1538 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
BM667933 eye, lens .d 1428 to 1825 416 to 19   fully sequenced, AAA   398/398
(100 %)
0 diff
(100 %id)
R98808 liver and spleen .d 1439 to 1829 396 to 3       394/398
(98 %)
0 diff
(100 %id)
CA773428 Pancreas, Purified pancreatic islet .d 1444 to 1825 392 to 11   AAA   382/382
(100 %)
4 diff
(99.0 %id)
BE242393 leukopheresis .d 1454 to 1825 372 to 1       372/372
(100 %)
3 diff
(99.2 %id)
BM770122 Ascites, stomach .d 1462 to 1825 1 to 364   AAA   364/364
(100 %)
0 diff
(100 %id)
BM770162 Ascites, stomach .d 1462 to 1825 1 to 364   AAA   364/364
(100 %)
0 diff
(100 %id)
BM771829 Ascites, stomach .d 1462 to 1825 1 to 364   AAA   364/364
(100 %)
0 diff
(100 %id)
BM741565 stomach .d 1484 to 1825 1 to 342   AAA   342/342
(100 %)
0 diff
(100 %id)
AA205520   .d 1514 to 1828 315 to 1       315/315
(100 %)
0 diff
(100 %id)
T16806   .d 1519 to 1825 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BE242970 leukopheresis .d 1524 to 1825 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AA044393 uterus .d 1564 to 1827 270 to 1   fully sequenced,   270/270
(100 %)
1 diff
(99.7 %id)
AA147731   .d 1573 to 1826 253 to 1   fully sequenced,   253/253
(100 %)
0 diff
(100 %id)
BE328269 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1687 to 1825 139 to 1       139/139
(100 %)
0 diff
(100 %id)
AW196201 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1733 to 1826 94 to 1       94/94
(100 %)
0 diff
(100 %id)
EH337355   .d 1753 to 1828 1 to 76   AAA   76/76
(100 %)
0 diff
(100 %id)
AA724501 parathyroid gland, parathyroid tumor .d 1754 to 1825 91 to 20   AAA   72/72
(100 %)
0 diff
(100 %id)
AA824612 germinal center B cell .d 1763 to 1825 82 to 20   AAA   63/63
(100 %)
0 diff
(100 %id)
CR623738 neuroblastoma .e 1 to 1715 2 to 1716 exact tiling clone,   1716/1716
(100 %)
0 diff
(100 %id)
AL517238 brain, neuroblastoma, neuroblastoma cells .e 1 to 918 2 to 919   fully sequenced,   919/919
(100 %)
10 diff
(99.0 %id)
CR591931 placenta .e 22 to 1140 1 to 1119       1119/1119
(100 %)
0 diff
(100 %id)
AL542872 placenta .e 22 to 944 1 to 923   fully sequenced,   923/923
(100 %)
3 diff
(99.7 %id)
BM559953 brain, medulla .e 23 to 1014 1 to 999       999/1043
(95 %)
33 diff
(96.9 %id)
BF969538 adrenal cortex carcinoma, cell line, adrenal gland .e 277 to 1062 1 to 779       779/842
(92 %)
27 diff
(96.8 %id)
BG283879 adenocarcinoma, cell line, Prostate .e 425 to 1258 1 to 828       828/866
(95 %)
18 diff
(98.0 %id)
BF970189 adrenal cortex carcinoma, cell line, adrenal gland .e 436 to 958 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
BM467822 leiomyosarcoma, uterus .e 436 to 1524 1 to 1079       1079/1079
(100 %)
30 diff
(97.3 %id)
BE395127 endometrium, adenocarcinoma cell line, uterus .e 459 to 1136 1 to 674       674/674
(100 %)
10 diff
(98.6 %id)
CB131732 cervix, Uterine .e 468 to 1041 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
CB140820 Liver .e 525 to 1137 1 to 613       613/613
(100 %)
7 diff
(98.9 %id)
CB145025 Liver .e 565 to 965 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BU179262 epithelioid carcinoma, Pancreas .e 675 to 1547 1 to 889       889/901
(98 %)
23 diff
(97.5 %id)
CB142638 Liver .e 684 to 1220 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BG220171   .e 688 to 1500 1 to 811       811/811
(100 %)
28 diff
(96.6 %id)
BG193193   .e 689 to 1493 1 to 801       801/801
(100 %)
14 diff
(98.3 %id)
BG203905   .e 689 to 1483 1 to 792       792/792
(100 %)
23 diff
(97.1 %id)
BG208647   .e 689 to 1469 1 to 782       782/782
(100 %)
9 diff
(98.9 %id)
BG213943   .e 689 to 1464 1 to 776       776/777
(99 %)
26 diff
(96.7 %id)
BG217130   .e 689 to 1481 1 to 782       782/783
(99 %)
37 diff
(95.3 %id)
BG189016   .e 690 to 1463 1 to 773       773/774
(99 %)
4 diff
(99.5 %id)
BG198773   .e 690 to 1423 1 to 733       733/824
(88 %)
30 diff
(96.4 %id)
BG184807   .e 694 to 1493 4 to 795       792/797
(99 %)
36 diff
(95.5 %id)
BG221127   .e 705 to 1601 1 to 886       886/896
(98 %)
76 diff
(91.6 %id)
AL517237 brain, neuroblastoma, neuroblastoma cells .e 891 to 1715 826 to 1   fully sequenced,   826/826
(100 %)
12 diff
(98.6 %id)
AL542871 placenta .e 891 to 1140 250 to 1   fully sequenced,   250/250
(100 %)
2 diff
(99.2 %id)
BC041600 Brain, neuroblastoma .f 1 to 1780 3 to 1781 Q244S Q245N Q246R A247P G248A ... tiling clone, available from MGC, AAA   1781/1781
(100 %)
1 diff
(100.0 %id)
AB097041 lung .f 140 to 1780 1 to 1641 I13V tiling clone,   1641/1641
(100 %)
2 diff
(99.9 %id)
AB097040 lung .f 262 to 1780 1 to 1519       1519/1519
(100 %)
1 diff
(100.0 %id)
TI_45379155   .g 1 to 847 67 to 926   tiling clone,   860/1069
(80 %)
27 diff
(97.5 %id)
TI_45379156   .g 848 to 1585 749 to 2   tiling clone,   748/866
(86 %)
0 diff
(100 %id)
TI_157594305   .h 12 to 613 77 to 678 E128G P129T V160G M161N A162G ... tiling clone, Submitted on the opposite strand 630/678
(92 %)
24 diff
(96.5 %id)
CN411777 embryonic stem cells, cell lines H1, H7, andH9 .i 1 to 652 1 to 652   tiling clone,   652/652
(100 %)
3 diff
(99.6 %id)
AW976190   .i 254 to 892 1 to 640       640/640
(100 %)
5 diff
(99.3 %id)
AA281703 germinal center B cell .i 269 to 602 1 to 334       334/334
(100 %)
0 diff
(100 %id)
CB114414 Liver .i 313 to 922 1 to 610   tiling clone,   610/610
(100 %)
0 diff
(100 %id)
AW976248   .i 721 to 1353 632 to 1     Submitted on the opposite strand 632/634
(99 %)
10 diff
(98.5 %id)
BG928492 cartilage .i 736 to 1195 82 to 542       461/476
(96 %)
7 diff
(98.6 %id)
DB091513 testis .i 828 to 1389 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
AI333204 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 850 to 1354 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AW118153 pooled .i 887 to 1354 469 to 1   tiling clone,   469/469
(100 %)
2 diff
(99.6 %id)
AI150613 heart .i 889 to 1357 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AI150614 heart .i 889 to 1354 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AW268494 pooled .i 890 to 1354 465 to 1       465/465
(100 %)
8 diff
(98.3 %id)
AI332517 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 908 to 1354 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AK123588 tongue, tumor tissue .i 940 to 4210 1 to 3272 exact tiling clone, available from FLJ,   3272/3272
(100 %)
5 diff
(99.9 %id)
DA450785 tongue, tumor tissue .i 941 to 1439 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
AW086443 ovary, papillary serous carcinoma .i 956 to 1363 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI350991   .i 963 to 1354 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AA749279 germinal center B cell .i 970 to 1363 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AW296435   .i 972 to 1354 400 to 18   AAA   383/383
(100 %)
0 diff
(100 %id)
AA836437 germinal center B cell .i 973 to 1365 393 to 1       393/393
(100 %)
2 diff
(99.5 %id)
AA885278 pooled .i 975 to 1354 380 to 1       380/380
(100 %)
1 diff
(99.8 %id)
AA281641 germinal center B cell .i 1001 to 1354 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
DA402595 thalamus .i 1058 to 1618 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
AA737400 germinal center B cell .i 1176 to 1365 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AI473304 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1177 to 1354 178 to 1       178/178
(100 %)
0 diff
(100 %id)
AA908819 ovary, serous adenocarcinoma .i 1185 to 1353 169 to 1       169/169
(100 %)
0 diff
(100 %id)
FN088891 breast carcinoma .i 1626 to 1709 83 to 1     Submitted on the opposite strand 83/83
(100 %)
1 diff
(98.8 %id)
BX110235 placenta .i 1771 to 2251 1 to 481   tiling clone,   481/481
(100 %)
1 diff
(99.8 %id)
FN073462 breast carcinoma .i 1824 to 1943 1 to 115       115/115
(100 %)
6 diff
(94.8 %id)
AI802023 carcinoid, lung .i 2087 to 2558 472 to 1   tiling clone,   472/472
(100 %)
0 diff
(100 %id)
BF111796 pooled .i 2093 to 2547 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AI301240 placenta .i 2148 to 2544 397 to 1       397/398
(99 %)
0 diff
(100 %id)
T19456   .i 2204 to 2546 1 to 344       344/375
(91 %)
10 diff
(97.4 %id)
AW614974 carcinoid, lung .i 2205 to 2555 372 to 22   AAA   351/351
(100 %)
4 diff
(98.9 %id)
AI908188 breast .i 2311 to 2815 1 to 506       506/508
(99 %)
8 diff
(98.5 %id)
DA812761 ovary, tumor tissue .i 2402 to 3217 2 to 818   capped   817/817
(100 %)
8 diff
(99.1 %id)
AW511313 pooled .i 2814 to 3295 484 to 3   tiling clone,   482/484
(99 %)
0 diff
(100 %id)
BE147076 head_neck .i 2820 to 3305 497 to 10     Submitted on the opposite strand 488/497
(98 %)
0 diff
(100 %id)
FN154543 breast carcinoma .i 2877 to 2957 79 to 1     Submitted on the opposite strand 79/80
(98 %)
2 diff
(97.5 %id)
DB372241 ovary, tumor tissue .i 3667 to 4210 542 to 1   tiling clone,   542/542
(100 %)
13 diff
(97.7 %id)
DB314211 tongue, tumor tissue .i 3685 to 4210 528 to 1       528/528
(100 %)
3 diff
(99.5 %id)
DA626001 Kidney .j 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
CN296088 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 165 to 912 1 to 747 G127V N173T Q174K D175M E176K ... tiling clone,   747/747
(100 %)
3 diff
(99.6 %id)
BM907110 brain, hippocampus .k 1 to 912 7 to 925 T54A S110R T122Y L124P P125S ... tiling clone,   919/1079
(85 %)
21 diff
(98.1 %id)
DB057656 testis .l 1 to 542 3 to 545   tiling clone, capped   544/544
(100 %)
4 diff
(99.3 %id)
DA748018   .l 43 to 613 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA625434 Kidney .l 48 to 582 8 to 542   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB043246 testis .l 48 to 610 12 to 574   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA693152   .l 53 to 634 2 to 583   tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
DA654586   .l 126 to 691 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BI560390 testis .l 128 to 816 5 to 693       689/693
(99 %)
9 diff
(98.8 %id)
TI_44349037   .l 128 to 816 125 to 813       689/813
(84 %)
7 diff
(99.2 %id)
DA107642 cerebellum .l 159 to 696 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
AA081663   .l 165 to 500 1 to 337       337/337
(100 %)
5 diff
(98.6 %id)
DB058998 testis .l 166 to 687 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA686594   .l 180 to 707 2 to 530   capped   529/529
(100 %)
3 diff
(99.5 %id)
AI128946 senescent fibroblast .l 395 to 863 1 to 474 G139D S140T W141V tiling clone, Submitted on the opposite strand 474/475
(99 %)
7 diff
(98.6 %id)
DB219854 trachea .m-u 1 to 286 2 to 287   tiling clone, capped   286/288
(99 %)
2 diff
(99.4 %id)
DA315166 hippocampus .m-u 13 to 593 2 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
AW340976 carcinoid, lung .m-u 496 to 1037 542 to 1   tiling clone,   542/542
(100 %)
1 diff
(99.9 %id)
AK127920 Spleen .m-u 531 to 3492 1 to 2962 exact tiling clone, available from FLJ,   2962/2962
(100 %)
2 diff
(100.0 %id)
DA948495 Spleen .m-u 532 to 1072 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
AW009498 colon .m-u 579 to 1027 458 to 10       449/458
(98 %)
0 diff
(100 %id)
AA975925 carcinoid, lung .m-u 711 to 1037 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AI333287 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m-u 819 to 1282 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
BX090025 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m-u 842 to 1294 456 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 454/456
(99 %)
0 diff
(100 %id)
AI801500 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m-u 883 to 1284 402 to 1       402/402
(100 %)
0 diff
(100 %id)
DN915187   .m-u 983 to 1644 1 to 655       655/663
(98 %)
10 diff
(98.5 %id)
DA923291 small intestine .m-u 1216 to 1768 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DN915186   .m-u 1253 to 1685 433 to 1       433/433
(100 %)
3 diff
(99.4 %id)
DA009631 adrenal gland .m-u 1462 to 2019 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
AA521030 germinal center B cell .m-u 1462 to 2042 573 to 2   tiling clone,   572/600
(95 %)
0 diff
(100 %id)
DA829436 placenta .m-u 1654 to 2352 2 to 706   capped   705/768
(91 %)
16 diff
(98.0 %id)
CD518668 White Matter .m-u 2117 to 2870 1 to 762       762/907
(84 %)
11 diff
(98.8 %id)
DN913684   .m-u 2118 to 2491 1 to 373       373/373
(100 %)
2 diff
(99.5 %id)
DN916996   .m-u 2118 to 2546 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
DN918370   .m-u 2118 to 2546 1 to 429       429/429
(100 %)
3 diff
(99.4 %id)
DN918371   .m-u 2118 to 2546 429 to 1       429/429
(100 %)
3 diff
(99.4 %id)
DN919750   .m-u 2118 to 2546 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
DN913685   .m-u 2198 to 2546 348 to 1       348/348
(100 %)
2 diff
(99.5 %id)
CN295313 embryonic stem cells, DMSO-treated H9 cellline .m-u 2370 to 3162 1 to 794 L17P     794/794
(100 %)
2 diff
(99.8 %id)
CD511418 Blood vessels - aorta, basilar and artery .m-u 2429 to 3083 1 to 667 exact     667/784
(85 %)
15 diff
(98.1 %id)
DB308718 hippocampus .m-u 2932 to 3492 561 to 1       561/561
(100 %)
1 diff
(99.9 %id)
DB332031 small intestine .m-u 2951 to 3492 542 to 1       542/542
(100 %)
1 diff
(99.9 %id)
DB374261 placenta .m-u 3039 to 3492 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
CB992101 placenta, pre-eclamptic placenta .n-u 1 to 680 28 to 708 exact tiling clone,   681/824
(82 %)
5 diff
(99.4 %id)
DB144869 thymus .n-u 273 to 816 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
CD359213 testis .o-u 1 to 677 1 to 684 R7Y E8A V9G A10R E11G ... tiling clone,   684/967
(70 %)
32 diff
(96.7 %id)
DB056869 testis .p 1 to 524 8 to 533   tiling clone, capped   532/532
(100 %)
2 diff
(99.7 %id)
EC477079 Prostate .p 511 to 640 124 to 1   tiling clone,   124/124
(100 %)
7 diff
(94.4 %id)
BG699975 brain, hippocampus .q 1 to 629 1 to 630 R2G C59L E60R R61A G62R ... tiling clone,   630/631
(99 %)
8 diff
(98.8 %id)
BI547456 brain, hippocampus .q 1 to 575 1 to 575 R2G G71A tiling clone,   575/575
(100 %)
6 diff
(99.0 %id)
TI_44168411   .q 6 to 575 92 to 661       570/661
(86 %)
6 diff
(99.1 %id)
DB032004 testis .r 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
BQ319390 colon .s-u 1 to 360 1 to 358 F6W D7I F8C C9V R10G ... tiling clone,   358/361
(99 %)
13 diff
(96.4 %id)
ES312723 beard hair, skin .t 1 to 145 1 to 146 exact tiling clone,   146/146
(100 %)
4 diff
(97.3 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n-u, .o-u, .p, .q, .r, .s-u, .t Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI